Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News   Press Releases

32 Biggest Movers From Yesterday

ACMR, ONCT, IPI, BRFS, GRPN, MGNX, NEXT | March 6, 2018

Gainers

  • Innovate Biopharmaceuticals Inc (NASDAQ: INNT) shares jumped 82.49 percent to close at $17.30 on Monday after climbing 54.15 percent on Friday.
  • Vericel Corp (NASDAQ: VCEL) shares rose 41.92 percent to close at $11.85 following better-than-expected Q4 earnings.
  • GTx, Inc. (NASDAQ: GTXI) gained 38.31 percent to close at $23.25 as the company issued Phase 2 data for enobosarm for urinary incontinence.
  • Clearside Biomedical Inc (NASDAQ: CLSD) jumped 32.1 percent to close at $10.33 on Monday after the clinical biopharmaceutical company announced an encouraging update from ongoing clinical studies. The company said its pivotal phase 3 clinical trial of its suprachoroidal CLS-TA in patients with macular edema achieved positive topline results.
  • Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares gained 31.4 percent to close at $2.72.
  • XL Group Ltd. (NYSE: XL) shares rose 29.15 percent to close at $55.92 after the insurance company agreed to sell itself to France's AXA for $15 billion, or $57.60 per share.
  • ITUS Corp (NASDAQ: ITUS) shares rose 17.79 percent to close at $3.84 after the company reported a partnership with Serametrix for ITUS' Cchek.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) shares surged 17.45 percent to close at $5.25 on Monday.
  • Kazia Therapeutics Limited (NASDAQ: KZIA) rose 16.41 percent to close at $5.93.
  • Odonate Therapeutics, Inc. (NASDAQ: ODT) shares jumped 13.93 percent to close at $31.00 on Monday.
  • Stitch Fix, Inc. (NASDAQ: SFIX) shares rose 13.51 percent to close at $24.70.
  • Upland Software, Inc. (NASDAQ: UPLD) shares jumped 12.19 percent to close at $27.25 on Monday. Upland Software is expected to release Q4 earnings on March 8.
  • Intrepid Potash, Inc. (NYSE: IPI) gained 11.8 percent to close at $3.98. Cowen & Co. upgraded Intrepid Potash from Underperform to Market Perform.
  • Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 11.73 percent to close at $30.77. Catalyst Biosciences reported the calling of remaining warrants and conversion of remaining Series A Preferred Stock issued April 12, 2017.
  • Corindus Vascular Robotics Inc (NYSE: CVRS) climbed 10.48 percent to close at $1.16. The developer of precision vascular robotics announced it has received a 510(k) clearance from the U.S. Food and Drug Administration for its automated robotic movement designed for the CorPath GRX platform.
  • Tyme Technologies Inc (NASDAQ: TYME) gained 9.17 percent to close at $2.50.
  • ACM Research Inc (NASDAQ: ACMR) rose 8.5 percent to close at $7.855 after the company reported upbeat Q4 results.
  • MacroGenics Inc (NASDAQ: MGNX) gained 7.12 percent to close at $31.00. H.C. Wainwright initiated coverage on MacroGenics with a Buy rating.
  • Casa Systems Inc (NASDAQ: CASA) shares rose 7.06 percent to close at $23.50.
  • Aimmune Therapeutics Inc (NASDAQ: AIMT) shares gained 5.58 percent to close at $35.97 after the company presented results from its pivotal Phase 3 PALISADE trial of AR101 for peanut allergy at the AAAAI-WAO.
  • Groupon Inc (NASDAQ: GRPN) climbed 5.15 percent to close at $4.49. Morgan Stanley upgraded Groupon from Underweight to Equal-Weight.


Losers

  • Dermira Inc (NASDAQ: DERM) shares dipped 65.86 percent to close at $8.59 on Monday as the company disclosed that its two Phase 3 trials evaluating olumacostat glasaretil in patients with acne vulgaris did not meet co-primary endpoints.
  • Sparton Corporation (NYSE: SPA) dropped 27.15 percent to close at $16.64 after the company reported termination of merger agreement with Ultra.
  • Camber Energy, Inc. (NYSE: CEI) shares fell 23.09 percent to close at $1.890 as 1-for-25 reverse stock split took effect.
  • Smith Micro Software, Inc. (NASDAQ: SMSI) tumbled 21.4 percent to close at $1.69 as the company announced a $5 million private placement.
  • BRF SA (ADR) (NYSE: BRFS) shares fell 19.43 percent to close at $7.59.
  • Nextdecade Corp (NASDAQ: NEXT) shares dipped 18.3 percent to close at $5.155.
  • Yangtze River Port and Logistics Limited (NASDAQ: YRIV) shares fell 10.92 percent to close at $4.08 on Monday.
  • Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares dropped 9.66 percent to close at $3.975.
  • Vectrus Inc (NYSE: VEC) declined 9.01 percent to close at $33.62. Drexel Hamilton downgraded Vectrus from Buy to Hold.
  • AnaptysBio, Inc. (NASDAQ: ANAB) fell 7.45 percent to close at $118.97 following Q4 results.
  • Essendant Inc. (NASDAQ: ESND) declined 7.35 percent to close at $7.44.

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Related News

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today